â€‹â€‹â€‹â€‹Patients of type two diabetes got some relief yesterday after a new oral drug to manage the disease was launched. The drug improves glycemic control, diet and exercise in adults. Its intorduction was announced during a scientific conference in Nairobi by Boehringer Ingelheim, one of the world’s leading pharmaceutical companies. Ayman Eissa, head of Boehringer Ingelheim, said lack of awareness and an increasing prevalence of the disease had become obstacles to reducing the rise of diabetes. The drug is available only as prescription medicine upon recommendation by a doctor. It is simple. effective and safe, the experts said.     